Jennifer Simpson | executive |
Susan Horvath | executive |
Jonathan Aschoff | analyst |
Joshua Korsen | analyst |
Greetings. Welcome to Panbela Therapeutics Fourth Quarter 2023 Earnings Call. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to your host, James Carbonara, Investor Relations. James, you may begin.